Doses will be ready to ship to applicable EU member states immediately upon authorization by the European Commission
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Renews GMP certifications for India and Malaysia sites
The company will now explore a buyer for its manufacturing site and exit in due course
Austin assumes role from Glenn F. Tilton, who will continue to serve as an independent director
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Higher efficacy was observed in mRNA-1283 compared to Spikevax in adults 18 years of age and older
Subscribe To Our Newsletter & Stay Updated
